FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091511 [Registered on: 23/07/2025] Trial Registered Prospectively
Last Modified On: 22/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Study comparing two nerve block techniques to control pain after caesarean delivery. 
Scientific Title of Study   Comparison of erector spinae plane block and transversus abdominis plane block with dexmedetomidine as adjuvant for post operative analgesia after caesarean section under spinal anaesthesia. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sahla Parveen 
Designation  Postgraduate Resident  
Affiliation  VMMC and Safdarjung Hospital  
Address  Department of Anaesthesia and intensive care, VMMC and Safdarjung Hospital, Ansari Nagar East, New Delhi
Thekkepurath house, Palachuvadu, Kakkanad P.O, Kochi ,682030,Kerala
South
DELHI
110029
India 
Phone  9847174452  
Fax    
Email  parveensahla26@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrRanju Gandhi 
Designation  Director Professor 
Affiliation  VMMC and Safdarjung Hospital 
Address  Department of Anaesthesia and intensive care, VMMC and Safdarjung Hospital, Ansari Nagar East, New Delhi

New Delhi
DELHI
110029
India 
Phone  9818941341  
Fax    
Email  icu_era@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  DrRanju Gandhi 
Designation  Director Professor 
Affiliation  VMMC and Safdarjung Hospital 
Address  Department of Anaesthesia and intensive care, VMMC and Safdarjung Hospital, Ansari Nagar East, New Delhi

New Delhi
DELHI
110029
India 
Phone  9818941341  
Fax    
Email  icu_era@yahoo.co.in  
 
Source of Monetary or Material Support  
Vardhman Mahavir Medical College and Safdarjung Hospital, Ansari Nagar West, New Delhi, Delhi 110029, India 
 
Primary Sponsor  
Name  Vardhman Mahavir Medical College and Safdarjung Hospital 
Address  Vardhman Mahavir Medical College and Safdarjung Hospital, Ansari Nagar West, New Delhi, Delhi 110029, India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrSahla Parveen  Vardhman Mahavir medical college and Safdarjung hospital, New Delhi   Department of anaesthesia and intensive care, main OT complex , ground floor.
South
DELHI 
9847174452

parveensahla26@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Vardhman Mahavir Medical College Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Erector spinae plane block  The ESP blocks will be performed with patients in the right lateral decubitus position. Using USG correct space will be identified and confirmed.Bupivacaine 0.25% 20 mL with dexmedetomidine (0.25 micrograms/cc) will be injected under vision. This procedure will be then repeated on the other side of the spine.  
Intervention  Transversus abdominis plane block  The TAP blocks will be performed in the supine position, using a linear (6-13 MHz) ultrasound transducer. After sterilization of the skin, a 21 gauge 100 mm echogenic needle will be introduced from anterior to posterior, and confirmation of correct needle placement will be made by separation of the muscle layers with sterile saline hydro dissection. After aspiration to exclude intravascular injection, bupivacaine 0.25% 20 mL with 0.25 mcg dexmedetomidine will be injected under vision. This procedure will be then repeated on the other side of the abdomen. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  American Society of Anaesthesiologists physical status II, or III normal singleton pregnancy (with a gestational age of at minimum 37 weeks) undergoing caesarean section under spinal anaesthesia. 
 
ExclusionCriteria 
Details  Any contraindication to spinal anaesthesia (systemic coagulopathy, anatomic abnormalities, localized infection), known allergy to study medication, inability to comprehend or participate in pain scoring system. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To compare the analgesic efficacy of erector spinae plane block and transversus abdominis plane block with dexmedetomidine as adjuvant for post op analgesia after caesarean section under spinal anaesthesia by assessing the time for first rescue analgesia.  Patients will be followed up at baseline,6 hours, 12 hours, 24 hours,36 hours, and 48 hours. 
 
Secondary Outcome  
Outcome  TimePoints 
1.Visual analogue scale (resting & dynamic) will be assessed at rest & on movement at
intervals of 6 hourly till 24 hours & the 12 hourly till 48 hours. (0,6,12,24,36,48 hours).
 
Patients will be followed up at baseline,6 hours, 12 hours, 24 hours,36 hours, & 48 hours. 
2.Total tramadol consumption for 48 hours   Calculated at the end of 48 hours. 
3.Adverse effects if any like hypotension, bradycardia, sedation.  Patients will be followed up at baseline,6 hours, 12 hours, 24 hours,36 hours, & 48 hours. 
4.Severity of pain interference with performance of activities of daily living (ADL) breastfeeding, & general care (cleaning, changing, comforting) of the infant. ADLs assessed will include include changing position in bed, standing & walking, & eating  Patients will be followed up at baseline,6 hours, 12 hours, 24 hours,36 hours, & 48 hours. 
5.Patient’s overall satisfaction score at discharge using 0-5 score (0 = worst ,1= very bad, 2 = bad, 3 = good, 4 = very good, 5 = best).  Assessed at time of discharge. 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   18/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a prospective interventional randomised comparative study to compare erector spinae plane block with transversus abdominis plane block  with dexmedetomidine as an adjuvant for post operative analgesia after caesarean section under spinal anaesthesia with the hypothesis that the use of erector spinae plane block is comparable to transversus abdominis plane block with dexmedetomidine as adjuvant for post operative analgesia for caesarean section under spinal anaesthesia.Primary objective is to compare the analgesic efficacy of erector spinae plane block and transversus abdominis plane block with dexmedetomidine as adjuvant for post op analgesia after caesarean section under spinal anaesthesia by assessing the time for first rescue analgesia.Secondary objectives are visual analogue scale (resting and dynamic) will be assessed at rest and on movement at intervals of 6 hourly till 24 hours and the 12 hourly till 48 hours. (0,6,12,24,36,48 hours),total tramadol consumption for 48 hours ,adverse effects if any like hypotension, bradycardia, sedation,severity of pain interference with performance of activities of daily living (ADL) breastfeeding, and general care (cleaning, changing, comforting) of the infant. ADLs assessed will include include changing position in bed, standing and walking, and eatingpatient’s overall satisfaction score at discharge using 0-5 score (0 = worst ,1= very bad, 2 = bad, 3 = good, 4 = very good, 5 = best).The sample size studied would be 80, ie, 40 per group.


 
Close